Latest Articles

Publication Date
Mali Barbi, MD, MS, on Endometrial Cancer: Data in dMMR Disease and B7-H4 ADCs for Advanced Disease - The ASCO Post

Mali Barbi, MD, MS, on Endometrial Cancer: Data in dMMR Disease and B7-H4 ADCs for Advanced Disease The ASCO Post

Published: June 8, 2026, 4:29 p.m.
Mali Barbi: ASCO 2026 Endometrial Cancer Recap Highlights Potential Curative Signal in dMMR Subtype - Oncodaily

Mali Barbi: ASCO 2026 Endometrial Cancer Recap Highlights Potential Curative Signal in dMMR Subtype Oncodaily

Published: June 7, 2026, 6:12 a.m.
Ramez N. Eskander, MD, on Endometrial Cancer: Pembrolizumab Plus Carboplatin/Paclitaxel - The ASCO Post

Ramez N. Eskander, MD, on Endometrial Cancer: Pembrolizumab Plus Carboplatin/Paclitaxel The ASCO Post

Published: June 5, 2026, 2:51 a.m.
Noelle Cloven, MD, on RAINFOL-03: Actively Recruiting Trial in Pretreated Endometrial Cancer - The ASCO Post

Noelle Cloven, MD, on RAINFOL-03: Actively Recruiting Trial in Pretreated Endometrial Cancer The ASCO Post

Published: June 4, 2026, 10:12 p.m.
KPTI: Phase III data in myelofibrosis and endometrial cancer signal major advances and rapid adoption - TradingView

KPTI: Phase III data in myelofibrosis and endometrial cancer signal major advances and rapid adoption TradingView

Published: June 4, 2026, 1:28 p.m.
Karyopharm to Participate in Webcast Featuring Endometrial Cancer Key Opinion Leader on June 8, 2026 - Karyopharm

Karyopharm to Participate in Webcast Featuring Endometrial Cancer Key Opinion Leader on June 8, 2026 Karyopharm

Published: June 3, 2026, 10:53 p.m.
The same molecular group that slows colorectal cancer drives endometrial cancer in a Lleida study - apd.cat

The same molecular group that slows colorectal cancer drives endometrial cancer in a Lleida study apd.cat

Published: June 3, 2026, 3:47 p.m.
Addition of Pembrolizumab to Chemotherapy Continues to Demonstrate Overall Survival Benefit in Advanced or Recurrent Endometrial Cancer - The ASCO Post

Addition of Pembrolizumab to Chemotherapy Continues to Demonstrate Overall Survival Benefit in Advanced or Recurrent Endometrial Cancer The ASCO Post

Published: June 3, 2026, 2:49 p.m.
Robin Quivers Announces Remission Following Endometrial Cancer Battle - sekbernews.id

Robin Quivers Announces Remission Following Endometrial Cancer Battle sekbernews.id

Published: June 3, 2026, 2:32 p.m.
Robin Quivers Announces Remission Following Extended Endometrial Cancer Battle - HarianBasis.co

Robin Quivers Announces Remission Following Extended Endometrial Cancer Battle HarianBasis.co

Published: June 3, 2026, 2:31 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!